首页 | 本学科首页   官方微博 | 高级检索  
     


Metabolic improvement with short-term,glucagon-like peptide-1 receptor agonist treatment does not improve cardiac diastolic dysfunction in patients with type 2 diabetes: A randomized,double-blind,placebo-controlled trial
Authors:Annemie Stege Bojer MD  Martin Heyn Sørensen MD  Jenny Bjerre MD  Peter Gæde MD  Niels Vejlstrup MD  Per Lav Madsen MD
Affiliation:1. Department of Cardiology and Endocrinology, Slagelse Hospital, Slagelse, Denmark;2. Department of Cardiology, Copenhagen University Hospital Bispebjerg, Copenhagen, Denmark;3. Department of Cardiology, Rigshospitalet, Copenhagen, Denmark;4. Department of Cardiology, Copenhagen University Hospital Herlev-Gentofte, Copenhagen, Denmark
Abstract:
Keywords:cardiac function  cardiovascular magnetic resonance imaging  diastolic function  glucagon-like peptide-1 receptor agonist  liraglutide  type 2 diabetes
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号